QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 15, Issue 2, 497-505, February 2004

This Article Full Text Full Text (PDF) All Versions of this Article: E03-05-0351v1 15/2/497    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilson, E. M. Articles by Rotwein, P. Search for Related Content PubMed PubMed Citation Articles by Wilson, E. M. Articles by Rotwein, P.

Permissive Roles of Phosphatidyl Inositol 3-Kinase and Akt in Skeletal Myocyte Maturation

Molecular Medicine Division, Oregon Health and Science University, Portland, Oregon 97239

Submitted May 30, 2003; Revised July 29, 2003; Accepted October 9, 2003
Monitoring Editor: Marvin Wickens

Skeletal muscle differentiation, maturation, and regeneration are regulated by interactions between signaling pathways activated by hormones and growth factors, and intrinsic genetic programs controlled by myogenic transcription factors, including members of the MyoD and myocyte enhancer factor 2 (MEF2) families. Insulin-like growth factors (IGFs) play key roles in muscle development in the embryo, and in the maintenance and hypertrophy of mature muscle in the adult, but the precise signaling pathways responsible for these effects remain incompletely defined. To study mechanisms of IGF action in muscle, we have developed a mouse myoblast cell line termed C2BP5 that is dependent on activation of the IGF-I receptor and the phosphatidyl inositol 3-kinase (PI3-kinase)-Akt pathway for initiation of differentiation. Here, we show that differentiation of C2BP5 myoblasts could be induced in the absence of IGF action by recombinant adenoviruses expressing MyoD or myogenin, but it was reversibly impaired by the PI3-kinase inhibitor LY294002. Similar results were observed using a dominant-negative version of Akt, a key downstream component of PI3-kinase signaling, and also were seen in C3H 10T1/2 fibroblasts. Inhibition of PI3-kinase did not prevent accumulation of muscle differentiation-specific proteins (myogenin, troponin T, or myosin heavy chain), did not block transcriptional activation of E-box containing muscle reporter genes by MyoD or myogenin, and did not inhibit the expression or function of endogenous MEF2C or MEF2D. An adenovirus encoding active Akt could partially restore terminal differentiation of MyoD-expressing and LY294002-treated myoblasts, but the resultant myofibers contained fewer nuclei and were smaller and thinner than normal, indicating that another PI3-kinase-stimulated pathway in addition to Akt is required for full myocyte maturation. Our results support the idea that an IGF-regulated PI3-kinase pathway functions downstream of or in parallel with MyoD, myogenin, and MEF2 in muscle development to govern the late steps of differentiation that lead to multinucleated myotubes.

Abbreviations used: DM, differentiation medium; IGF, insulin-like growth factor; IGFBP, insulin-like growth factor binding protein; MEF2, myocyte enhancer factor 2; MHC, myosin heavy chain; PI3-kinase, phosphatidyl inositol 3-kinase.

^* Corresponding author. E-mail address: rotweinp{at}ohsu.edu.

This article has been cited by other articles:

				K. Datta, T. Guan, and L. Gerace NET37, a Nuclear Envelope Transmembrane Protein with Glycosidase Homology, Is Involved in Myoblast Differentiation J. Biol. Chem., October 23, 2009; 284(43): 29666 - 29676. [Abstract] [Full Text] [PDF]

				L. Shu and P. J. Houghton The mTORC2 Complex Regulates Terminal Differentiation of C2C12 Myoblasts Mol. Cell. Biol., September 1, 2009; 29(17): 4691 - 4700. [Abstract] [Full Text] [PDF]

				G. Tripathi, D. A. M. Salih, A. C. Drozd, R. A. Cosgrove, L. J. Cobb, and J. M. Pell IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo FASEB J, August 1, 2009; 23(8): 2616 - 2626. [Abstract] [Full Text] [PDF]

				B. R. McKay, C. E. O'Reilly, S. M. Phillips, M. A. Tarnopolsky, and G. Parise Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans J. Physiol., November 15, 2008; 586(22): 5549 - 5560. [Abstract] [Full Text] [PDF]

				H. Ren, P. Yin, and C. Duan IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop J. Cell Biol., September 8, 2008; 182(5): 979 - 991. [Abstract] [Full Text] [PDF]

				A. Mukherjee and P. Rotwein Insulin-Like Growth Factor-Binding Protein-5 Inhibits Osteoblast Differentiation and Skeletal Growth by Blocking Insulin-Like Growth Factor Actions Mol. Endocrinol., May 1, 2008; 22(5): 1238 - 1250. [Abstract] [Full Text] [PDF]

				I. Plaisance, C. Morandi, C. Murigande, and M. Brink TNF-{alpha} increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E241 - E250. [Abstract] [Full Text] [PDF]

				A. Mukherjee, E. M. Wilson, and P. Rotwein Insulin-Like Growth Factor (IGF) Binding Protein-5 Blocks Skeletal Muscle Differentiation by Inhibiting IGF Actions Mol. Endocrinol., January 1, 2008; 22(1): 206 - 215. [Abstract] [Full Text] [PDF]

				C. Dogra, S. L. Hall, N. Wedhas, T. A. Linkhart, and A. Kumar Fibroblast Growth Factor Inducible 14 (Fn14) Is Required for the Expression of Myogenic Regulatory Factors and Differentiation of Myoblasts into Myotubes: EVIDENCE FOR TWEAK-INDEPENDENT FUNCTIONS OF Fn14 DURING MYOGENESIS J. Biol. Chem., May 18, 2007; 282(20): 15000 - 15010. [Abstract] [Full Text] [PDF]

				J. Fu, K. Menzies, R. S. Freeman, and M. B. Taubman EGLN3 Prolyl Hydroxylase Regulates Skeletal Muscle Differentiation and Myogenin Protein Stability J. Biol. Chem., April 27, 2007; 282(17): 12410 - 12418. [Abstract] [Full Text] [PDF]

				E. M. Wilson and P. Rotwein Selective Control of Skeletal Muscle Differentiation by Akt1 J. Biol. Chem., February 23, 2007; 282(8): 5106 - 5110. [Abstract] [Full Text] [PDF]

				M. I. Lewis Mechanisms underlying myogenesis: complex and likely to become more so! J Appl Physiol, December 1, 2006; 101(6): 1539 - 1540. [Full Text] [PDF]

				E. M. Wilson and P. Rotwein Control of MyoD Function during Initiation of Muscle Differentiation by an Autocrine Signaling Pathway Activated by Insulin-like Growth Factor-II J. Biol. Chem., October 6, 2006; 281(40): 29962 - 29971. [Abstract] [Full Text] [PDF]

				M. H. Parker, R. L. S. Perry, M. C. Fauteux, C. A. Berkes, and M. A. Rudnicki MyoD Synergizes with the E-Protein HEB{beta} To Induce Myogenic Differentiation Mol. Cell. Biol., August 1, 2006; 26(15): 5771 - 5783. [Abstract] [Full Text] [PDF]

				N. Wedhas, H. J. Klamut, C. Dogra, A. K. Srivastava, S. Mohan, and A. Kumar Inhibition of mechanosensitive cation channels inhibits myogenic differentiation by suppressing the expression of myogenic regulatory factors and caspase-3 activity FASEB J, December 1, 2005; 19(14): 1986 - 1997. [Abstract] [Full Text] [PDF]

				I.-H. Park and J. Chen Mammalian Target of Rapamycin (mTOR) Signaling Is Required for a Late-stage Fusion Process during Skeletal Myotube Maturation J. Biol. Chem., September 9, 2005; 280(36): 32009 - 32017. [Abstract] [Full Text] [PDF]

				E. E. Spangenburg SOCS-3 Induces Myoblast Differentiation J. Biol. Chem., March 18, 2005; 280(11): 10749 - 10758. [Abstract] [Full Text] [PDF]